BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

80 related articles for article (PubMed ID: 26566695)

  • 1. p53 R175H hydrophobic patch and H-bond reorganization observed by MD simulation.
    Thayer KM; Quinn TR
    Biopolymers; 2016 Mar; 105(3):176-85. PubMed ID: 26566695
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Molecular dynamics study on the inhibition mechanisms of ReACp53 peptide for p53-R175H mutant aggregation.
    Lei J; Cai M; Shen Y; Lin D; Deng X
    Phys Chem Chem Phys; 2021 Oct; 23(40):23032-23041. PubMed ID: 34612239
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Molecular dynamics simulations suggest Thiosemicarbazones can bind p53 cancer mutant R175H.
    Das T; Mukhopadhyay C
    Biochim Biophys Acta Proteins Proteom; 2023 May; 1871(3):140903. PubMed ID: 36731759
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Targeting the Prion-like Aggregation of Mutant p53 to Combat Cancer.
    Silva JL; Cino EA; Soares IN; Ferreira VF; A P de Oliveira G
    Acc Chem Res; 2018 Jan; 51(1):181-190. PubMed ID: 29260852
    [TBL] [Abstract][Full Text] [Related]  

  • 5. From mutational inactivation to aberrant gain-of-function: Unraveling the structural basis of mutant p53 oncogenic transition.
    Olotu FA; Soliman MES
    J Cell Biochem; 2018 Mar; 119(3):2646-2652. PubMed ID: 29058783
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Molecular dynamics simulations studies and free energy analysis on inhibitors of MDM2-p53 interaction.
    Niu RJ; Zheng QC; Zhang JL; Zhang HX
    J Mol Graph Model; 2013 Nov; 46():132-9. PubMed ID: 24211465
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Simulations of mutant p53 DNA binding domains reveal a novel druggable pocket.
    Pradhan MR; Siau JW; Kannan S; Nguyen MN; Ouaray Z; Kwoh CK; Lane DP; Ghadessy F; Verma CS
    Nucleic Acids Res; 2019 Feb; 47(4):1637-1652. PubMed ID: 30649466
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Structural characteristics of the hydrophobic patch of azurin and its interaction with p53: a site-directed spin labeling study.
    Xu C; Yin J; Zhao B
    Sci China Life Sci; 2010 Oct; 53(10):1181-8. PubMed ID: 20953940
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Common cancer mutations R175H and R273H drive the p53 DNA-binding domain towards aggregation-prone conformations.
    Li L; Li X; Tang Y; Lao Z; Lei J; Wei G
    Phys Chem Chem Phys; 2020 May; 22(17):9225-9232. PubMed ID: 32307496
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Virtual screening of p53 mutants reveals Y220S as an additional rescue drug target for PhiKan083 with higher binding characteristics.
    Raghavan V; Agrahari M; Gowda DK
    Comput Biol Chem; 2019 Jun; 80():398-408. PubMed ID: 31128451
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Insight into mechanism of small molecule inhibitors of the MDM2-p53 interaction: molecular dynamics simulation and free energy analysis.
    Chen J; Wang J; Xu B; Zhu W; Li G
    J Mol Graph Model; 2011 Sep; 30():46-53. PubMed ID: 21764342
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mechanistic insight into the destabilization of p53TD tetramer by cancer-related R337H mutation: a molecular dynamics study.
    Yu Y; Dong X; Tang Y; Li L; Wei G
    Phys Chem Chem Phys; 2022 Feb; 24(8):5199-5210. PubMed ID: 35166747
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Thermodynamic and computational studies on the binding of p53-derived peptides and peptidomimetic inhibitors to HDM2.
    Grässlin A; Amoreira C; Baldridge KK; Robinson JA
    Chembiochem; 2009 May; 10(8):1360-8. PubMed ID: 19408261
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Rational design of viscosity reducing mutants of a monoclonal antibody: hydrophobic versus electrostatic inter-molecular interactions.
    Nichols P; Li L; Kumar S; Buck PM; Singh SK; Goswami S; Balthazor B; Conley TR; Sek D; Allen MJ
    MAbs; 2015; 7(1):212-30. PubMed ID: 25559441
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Water's potential role: Insights from studies of the p53 core domain.
    Xu X; Ma Z; Wang X; Xiao ZT; Li Y; Xue ZH; Wang YH
    J Struct Biol; 2012 Feb; 177(2):358-66. PubMed ID: 22197648
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Group-based QSAR and molecular dynamics mechanistic analysis revealing the mode of action of novel piperidinone derived protein-protein inhibitors of p53-MDM2.
    Goyal S; Grover S; Dhanjal JK; Tyagi C; Goyal M; Grover A
    J Mol Graph Model; 2014 Jun; 51():64-72. PubMed ID: 24858256
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Carnosine inhibits Aβ(42) aggregation by perturbing the H-bond network in and around the central hydrophobic cluster.
    Attanasio F; Convertino M; Magno A; Caflisch A; Corazza A; Haridas H; Esposito G; Cataldo S; Pignataro B; Milardi D; Rizzarelli E
    Chembiochem; 2013 Mar; 14(5):583-92. PubMed ID: 23440928
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Molecular dynamics study of the recognition of dimethylated CpG sites by MBD1 protein.
    Bianchi C; Zangi R
    J Chem Inf Model; 2015 Mar; 55(3):636-44. PubMed ID: 25658035
    [TBL] [Abstract][Full Text] [Related]  

  • 19. New insight into the architecture of oxy-anion pocket in unliganded conformation of GAT domains: A MD-simulation study.
    Bairagya HR; Bansal M
    Proteins; 2016 Mar; 84(3):360-73. PubMed ID: 26756917
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of Zn2+ on DNA recognition and stability of the p53 DNA-binding domain.
    Duan J; Nilsson L
    Biochemistry; 2006 Jun; 45(24):7483-92. PubMed ID: 16768444
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.